nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Guanethidine—hypertension	0.0566	0.11	CbGbCtD
Rifaximin—CYP3A4—Hydralazine—hypertension	0.0429	0.0837	CbGbCtD
Rifaximin—CYP3A4—Guanfacine—hypertension	0.0365	0.0712	CbGbCtD
Rifaximin—CYP3A4—Isradipine—hypertension	0.0325	0.0634	CbGbCtD
Rifaximin—CYP3A4—Indapamide—hypertension	0.0286	0.0558	CbGbCtD
Rifaximin—CYP3A4—Nisoldipine—hypertension	0.0286	0.0558	CbGbCtD
Rifaximin—CYP3A4—Diltiazem—hypertension	0.0277	0.0539	CbGbCtD
Rifaximin—CYP3A4—Eplerenone—hypertension	0.0277	0.0539	CbGbCtD
Rifaximin—CYP3A4—Enalapril—hypertension	0.0246	0.0481	CbGbCtD
Rifaximin—CYP3A4—Irbesartan—hypertension	0.0225	0.044	CbGbCtD
Rifaximin—CYP3A4—Amlodipine—hypertension	0.0221	0.0431	CbGbCtD
Rifaximin—CYP3A4—Felodipine—hypertension	0.0213	0.0416	CbGbCtD
Rifaximin—CYP3A4—Nifedipine—hypertension	0.0206	0.0402	CbGbCtD
Rifaximin—CYP3A4—Nicardipine—hypertension	0.0203	0.0396	CbGbCtD
Rifaximin—CYP3A4—Carvedilol—hypertension	0.0203	0.0396	CbGbCtD
Rifaximin—CYP3A4—Propranolol—hypertension	0.0187	0.0364	CbGbCtD
Rifaximin—CYP3A4—Clonidine—hypertension	0.0178	0.0348	CbGbCtD
Rifaximin—CYP3A4—Atorvastatin—hypertension	0.0159	0.031	CbGbCtD
Rifaximin—CYP3A4—Losartan—hypertension	0.0145	0.0283	CbGbCtD
Rifaximin—CYP3A4—Verapamil—hypertension	0.0128	0.025	CbGbCtD
Rifaximin—Rifampicin—CYP4A11—hypertension	0.00322	0.485	CrCbGaD
Rifaximin—Rifampicin—ABCC1—hypertension	0.00132	0.199	CrCbGaD
Rifaximin—Rifapentine—CYP3A5—hypertension	0.00129	0.195	CrCbGaD
Rifaximin—Rifampicin—CYP3A5—hypertension	0.000806	0.121	CrCbGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B1—hypertension	0.000241	0.00517	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP11B1—hypertension	0.000237	0.0051	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NPPA—hypertension	0.000227	0.00488	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2J2—hypertension	0.000225	0.00484	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2J2—hypertension	0.000222	0.00477	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—TPH1—hypertension	0.000218	0.00468	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—COMT—hypertension	0.000212	0.00455	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4F12—hypertension	0.000211	0.00454	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—hypertension	0.000208	0.00448	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—hypertension	0.000202	0.00434	CbGpPWpGaD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—hypertension	0.0002	0.0043	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B1—hypertension	0.000195	0.00419	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—GSTM1—hypertension	0.000194	0.00416	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4A11—hypertension	0.000189	0.00407	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP4A11—hypertension	0.000187	0.00402	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—CYP1A1—hypertension	0.000184	0.00395	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2J2—hypertension	0.000182	0.00392	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—PTGIS—hypertension	0.000182	0.00392	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—hypertension	0.000182	0.00392	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—hypertension	0.00018	0.00387	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—CTGF—hypertension	0.000178	0.00383	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP2C18—hypertension	0.000178	0.00382	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR3C2—hypertension	0.000174	0.00374	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—hypertension	0.00017	0.00366	CbGpPWpGaD
Rifaximin—CYP3A4—Xenobiotics—CYP1A1—hypertension	0.000169	0.00363	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—hypertension	0.000168	0.00362	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ESR2—hypertension	0.000163	0.0035	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP1A1—hypertension	0.000162	0.00349	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—hypertension	0.000161	0.00346	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NOTCH2—hypertension	0.000154	0.00332	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4A11—hypertension	0.000154	0.0033	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—ALDH2—hypertension	0.000151	0.00324	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—HDAC1—hypertension	0.000148	0.00318	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—PTGIS—hypertension	0.000148	0.00318	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—hypertension	0.000148	0.00318	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NEDD4L—hypertension	0.000144	0.0031	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—AR—hypertension	0.000144	0.00309	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—hypertension	0.000144	0.00308	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—hypertension	0.000142	0.00304	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—hypertension	0.000138	0.00297	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—hypertension	0.000132	0.00283	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—hypertension	0.000131	0.00281	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—VDR—hypertension	0.000129	0.00278	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—GATA4—hypertension	0.000125	0.0027	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTA5—hypertension	0.000124	0.00267	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTA5—hypertension	0.000122	0.00263	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—hypertension	0.00012	0.00257	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—hypertension	0.000118	0.00254	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTT2—hypertension	0.000118	0.00253	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—hypertension	0.000117	0.00251	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—hypertension	0.000116	0.0025	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR3C1—hypertension	0.000116	0.0025	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTT2—hypertension	0.000116	0.00249	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP4F12—hypertension	0.000112	0.00241	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP4F12—hypertension	0.000111	0.00238	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—hypertension	0.00011	0.00236	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NPPA—hypertension	0.000109	0.00235	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARA—hypertension	0.000109	0.00234	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—hypertension	0.000108	0.00233	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP19A1—hypertension	0.000108	0.00231	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP11B1—hypertension	0.000104	0.00223	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—AHCY—hypertension	0.000104	0.00223	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP11B1—hypertension	0.000102	0.0022	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—hypertension	0.000101	0.00217	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTM5—hypertension	0.0001	0.00215	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—hypertension	9.89e-05	0.00213	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—EPHX2—hypertension	9.87e-05	0.00212	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTM5—hypertension	9.87e-05	0.00212	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—EPHX1—hypertension	9.87e-05	0.00212	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2J2—hypertension	9.69e-05	0.00208	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CAT—hypertension	9.68e-05	0.00208	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—hypertension	9.58e-05	0.00206	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2J2—hypertension	9.55e-05	0.00205	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NOTCH1—hypertension	9.55e-05	0.00205	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARG—hypertension	9.01e-05	0.00194	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—hypertension	8.91e-05	0.00191	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—hypertension	8.82e-05	0.0019	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—hypertension	8.69e-05	0.00187	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP1A1—hypertension	8.67e-05	0.00186	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—hypertension	8.58e-05	0.00184	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—CTGF—hypertension	8.57e-05	0.00184	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—hypertension	8.35e-05	0.00179	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP4A11—hypertension	8.15e-05	0.00175	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—SERPINE1—hypertension	8.12e-05	0.00174	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP3A5—hypertension	7.85e-05	0.00169	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—PTGIS—hypertension	7.85e-05	0.00169	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ESR2—hypertension	7.84e-05	0.00169	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP3A5—hypertension	7.74e-05	0.00166	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NOTCH2—hypertension	7.43e-05	0.0016	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP11B2—hypertension	7.34e-05	0.00158	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP11B2—hypertension	7.24e-05	0.00156	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HDAC1—hypertension	7.12e-05	0.00153	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—hypertension	7.05e-05	0.00152	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—hypertension	7.01e-05	0.00151	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—TBXAS1—hypertension	6.93e-05	0.00149	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AR—hypertension	6.93e-05	0.00149	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—hypertension	6.92e-05	0.00149	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—VDR—hypertension	6.22e-05	0.00134	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2C18—hypertension	6.18e-05	0.00133	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2C18—hypertension	6.1e-05	0.00131	CbGpPWpGaD
Rifaximin—Confusional state—Timolol—hypertension	6.06e-05	0.00014	CcSEcCtD
Rifaximin—Vomiting—Verapamil—hypertension	6.06e-05	0.00014	CcSEcCtD
Rifaximin—Urticaria—Irbesartan—hypertension	6.06e-05	0.000139	CcSEcCtD
Rifaximin—Shock—Ramipril—hypertension	6.05e-05	0.000139	CcSEcCtD
Rifaximin—Hypersensitivity—Enalapril—hypertension	6.05e-05	0.000139	CcSEcCtD
Rifaximin—Abdominal pain—Perindopril—hypertension	6.05e-05	0.000139	CcSEcCtD
Rifaximin—Body temperature increased—Perindopril—hypertension	6.05e-05	0.000139	CcSEcCtD
Rifaximin—Diarrhoea—Olmesartan—hypertension	6.04e-05	0.000139	CcSEcCtD
Rifaximin—Headache—Eplerenone—hypertension	6.04e-05	0.000139	CcSEcCtD
Rifaximin—Rash—Nifedipine—hypertension	6.03e-05	0.000139	CcSEcCtD
Rifaximin—Nervous system disorder—Ramipril—hypertension	6.03e-05	0.000139	CcSEcCtD
Rifaximin—Dermatitis—Nifedipine—hypertension	6.03e-05	0.000139	CcSEcCtD
Rifaximin—Abdominal pain—Irbesartan—hypertension	6.03e-05	0.000139	CcSEcCtD
Rifaximin—Body temperature increased—Irbesartan—hypertension	6.03e-05	0.000139	CcSEcCtD
Rifaximin—Anaphylactic shock—Timolol—hypertension	6.01e-05	0.000139	CcSEcCtD
Rifaximin—Loss of consciousness—Lisinopril—hypertension	6.01e-05	0.000138	CcSEcCtD
Rifaximin—Rash—Verapamil—hypertension	6.01e-05	0.000138	CcSEcCtD
Rifaximin—Urticaria—Hydrochlorothiazide—hypertension	6.01e-05	0.000138	CcSEcCtD
Rifaximin—Dermatitis—Verapamil—hypertension	6e-05	0.000138	CcSEcCtD
Rifaximin—Headache—Nifedipine—hypertension	5.99e-05	0.000138	CcSEcCtD
Rifaximin—Pruritus—Clonidine—hypertension	5.98e-05	0.000138	CcSEcCtD
Rifaximin—Body temperature increased—Hydrochlorothiazide—hypertension	5.98e-05	0.000138	CcSEcCtD
Rifaximin—Abdominal pain—Hydrochlorothiazide—hypertension	5.98e-05	0.000138	CcSEcCtD
Rifaximin—Skin disorder—Ramipril—hypertension	5.98e-05	0.000138	CcSEcCtD
Rifaximin—Infection—Timolol—hypertension	5.97e-05	0.000138	CcSEcCtD
Rifaximin—Headache—Verapamil—hypertension	5.97e-05	0.000137	CcSEcCtD
Rifaximin—Hypersensitivity—Telmisartan—hypertension	5.97e-05	0.000137	CcSEcCtD
Rifaximin—Cough—Lisinopril—hypertension	5.96e-05	0.000137	CcSEcCtD
Rifaximin—Nausea—Diltiazem—hypertension	5.95e-05	0.000137	CcSEcCtD
Rifaximin—Nausea—Indapamide—hypertension	5.95e-05	0.000137	CcSEcCtD
Rifaximin—Hyperhidrosis—Ramipril—hypertension	5.95e-05	0.000137	CcSEcCtD
Rifaximin—Asthenia—Trandolapril—hypertension	5.92e-05	0.000136	CcSEcCtD
Rifaximin—Shock—Timolol—hypertension	5.92e-05	0.000136	CcSEcCtD
Rifaximin—Feeling abnormal—Losartan—hypertension	5.91e-05	0.000136	CcSEcCtD
Rifaximin—Urticaria—Furosemide—hypertension	5.91e-05	0.000136	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—H2AFX—hypertension	5.9e-05	0.00127	CbGpPWpGaD
Rifaximin—Nervous system disorder—Timolol—hypertension	5.9e-05	0.000136	CcSEcCtD
Rifaximin—Nausea—Carvedilol—hypertension	5.9e-05	0.000136	CcSEcCtD
Rifaximin—Asthenia—Enalapril—hypertension	5.89e-05	0.000136	CcSEcCtD
Rifaximin—Abdominal pain—Furosemide—hypertension	5.88e-05	0.000135	CcSEcCtD
Rifaximin—Body temperature increased—Furosemide—hypertension	5.88e-05	0.000135	CcSEcCtD
Rifaximin—Gastrointestinal pain—Losartan—hypertension	5.87e-05	0.000135	CcSEcCtD
Rifaximin—Dizziness—Valsartan—hypertension	5.87e-05	0.000135	CcSEcCtD
Rifaximin—Anorexia—Ramipril—hypertension	5.86e-05	0.000135	CcSEcCtD
Rifaximin—Urticaria—Betaxolol—hypertension	5.85e-05	0.000135	CcSEcCtD
Rifaximin—Skin disorder—Timolol—hypertension	5.84e-05	0.000135	CcSEcCtD
Rifaximin—Dizziness—Olmesartan—hypertension	5.84e-05	0.000134	CcSEcCtD
Rifaximin—Pruritus—Trandolapril—hypertension	5.83e-05	0.000134	CcSEcCtD
Rifaximin—Nausea—Doxazosin—hypertension	5.83e-05	0.000134	CcSEcCtD
Rifaximin—Myalgia—Lisinopril—hypertension	5.82e-05	0.000134	CcSEcCtD
Rifaximin—Chest pain—Lisinopril—hypertension	5.82e-05	0.000134	CcSEcCtD
Rifaximin—Arthralgia—Lisinopril—hypertension	5.82e-05	0.000134	CcSEcCtD
Rifaximin—Body temperature increased—Betaxolol—hypertension	5.82e-05	0.000134	CcSEcCtD
Rifaximin—Hyperhidrosis—Timolol—hypertension	5.81e-05	0.000134	CcSEcCtD
Rifaximin—Asthenia—Telmisartan—hypertension	5.81e-05	0.000134	CcSEcCtD
Rifaximin—Pruritus—Enalapril—hypertension	5.81e-05	0.000134	CcSEcCtD
Rifaximin—Diarrhoea—Clonidine—hypertension	5.79e-05	0.000133	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	5.78e-05	0.000133	CcSEcCtD
Rifaximin—Nausea—Fosinopril—hypertension	5.76e-05	0.000133	CcSEcCtD
Rifaximin—Discomfort—Lisinopril—hypertension	5.75e-05	0.000132	CcSEcCtD
Rifaximin—Hypotension—Ramipril—hypertension	5.75e-05	0.000132	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—PRKCA—hypertension	5.74e-05	0.00123	CbGpPWpGaD
Rifaximin—Anorexia—Timolol—hypertension	5.73e-05	0.000132	CcSEcCtD
Rifaximin—Pruritus—Telmisartan—hypertension	5.73e-05	0.000132	CcSEcCtD
Rifaximin—Nausea—Eplerenone—hypertension	5.73e-05	0.000132	CcSEcCtD
Rifaximin—Urticaria—Losartan—hypertension	5.7e-05	0.000131	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—YWHAZ—hypertension	5.69e-05	0.00122	CbGpPWpGaD
Rifaximin—Dry mouth—Lisinopril—hypertension	5.69e-05	0.000131	CcSEcCtD
Rifaximin—Nausea—Nifedipine—hypertension	5.68e-05	0.000131	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—hypertension	5.68e-05	0.00122	CbGpPWpGaD
Rifaximin—Abdominal pain—Losartan—hypertension	5.67e-05	0.000131	CcSEcCtD
Rifaximin—Body temperature increased—Losartan—hypertension	5.67e-05	0.000131	CcSEcCtD
Rifaximin—Nausea—Verapamil—hypertension	5.66e-05	0.00013	CcSEcCtD
Rifaximin—Asthenia—Captopril—hypertension	5.65e-05	0.00013	CcSEcCtD
Rifaximin—Diarrhoea—Trandolapril—hypertension	5.64e-05	0.00013	CcSEcCtD
Rifaximin—Vomiting—Valsartan—hypertension	5.64e-05	0.00013	CcSEcCtD
Rifaximin—Confusional state—Lisinopril—hypertension	5.63e-05	0.00013	CcSEcCtD
Rifaximin—Diarrhoea—Enalapril—hypertension	5.62e-05	0.000129	CcSEcCtD
Rifaximin—Hypotension—Timolol—hypertension	5.62e-05	0.000129	CcSEcCtD
Rifaximin—Hypersensitivity—Irbesartan—hypertension	5.62e-05	0.000129	CcSEcCtD
Rifaximin—Vomiting—Olmesartan—hypertension	5.61e-05	0.000129	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Ramipril—hypertension	5.6e-05	0.000129	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NR3C1—hypertension	5.6e-05	0.0012	CbGpPWpGaD
Rifaximin—Rash—Valsartan—hypertension	5.59e-05	0.000129	CcSEcCtD
Rifaximin—Dizziness—Clonidine—hypertension	5.59e-05	0.000129	CcSEcCtD
Rifaximin—Dermatitis—Valsartan—hypertension	5.59e-05	0.000129	CcSEcCtD
Rifaximin—Anaphylactic shock—Lisinopril—hypertension	5.58e-05	0.000129	CcSEcCtD
Rifaximin—Pruritus—Captopril—hypertension	5.57e-05	0.000128	CcSEcCtD
Rifaximin—Hypersensitivity—Hydrochlorothiazide—hypertension	5.57e-05	0.000128	CcSEcCtD
Rifaximin—Rash—Olmesartan—hypertension	5.57e-05	0.000128	CcSEcCtD
Rifaximin—Insomnia—Ramipril—hypertension	5.56e-05	0.000128	CcSEcCtD
Rifaximin—Dermatitis—Olmesartan—hypertension	5.56e-05	0.000128	CcSEcCtD
Rifaximin—Headache—Valsartan—hypertension	5.56e-05	0.000128	CcSEcCtD
Rifaximin—Diarrhoea—Telmisartan—hypertension	5.54e-05	0.000128	CcSEcCtD
Rifaximin—Infection—Lisinopril—hypertension	5.54e-05	0.000128	CcSEcCtD
Rifaximin—Headache—Olmesartan—hypertension	5.53e-05	0.000127	CcSEcCtD
Rifaximin—Shock—Lisinopril—hypertension	5.49e-05	0.000126	CcSEcCtD
Rifaximin—Asthenia—Perindopril—hypertension	5.49e-05	0.000126	CcSEcCtD
Rifaximin—Dyspnoea—Ramipril—hypertension	5.48e-05	0.000126	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Timolol—hypertension	5.48e-05	0.000126	CcSEcCtD
Rifaximin—Hypersensitivity—Furosemide—hypertension	5.48e-05	0.000126	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—PRKCD—hypertension	5.47e-05	0.00118	CbGpPWpGaD
Rifaximin—Asthenia—Irbesartan—hypertension	5.47e-05	0.000126	CcSEcCtD
Rifaximin—Dizziness—Trandolapril—hypertension	5.45e-05	0.000126	CcSEcCtD
Rifaximin—Insomnia—Timolol—hypertension	5.44e-05	0.000125	CcSEcCtD
Rifaximin—Dizziness—Enalapril—hypertension	5.43e-05	0.000125	CcSEcCtD
Rifaximin—Asthenia—Hydrochlorothiazide—hypertension	5.42e-05	0.000125	CcSEcCtD
Rifaximin—Hypersensitivity—Betaxolol—hypertension	5.42e-05	0.000125	CcSEcCtD
Rifaximin—Skin disorder—Lisinopril—hypertension	5.42e-05	0.000125	CcSEcCtD
Rifaximin—Pruritus—Perindopril—hypertension	5.41e-05	0.000125	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—GPX3—hypertension	5.41e-05	0.00116	CbGpPWpGaD
Rifaximin—Pruritus—Irbesartan—hypertension	5.39e-05	0.000124	CcSEcCtD
Rifaximin—Hyperhidrosis—Lisinopril—hypertension	5.39e-05	0.000124	CcSEcCtD
Rifaximin—Diarrhoea—Captopril—hypertension	5.39e-05	0.000124	CcSEcCtD
Rifaximin—Vomiting—Clonidine—hypertension	5.38e-05	0.000124	CcSEcCtD
Rifaximin—Dyspnoea—Timolol—hypertension	5.36e-05	0.000123	CcSEcCtD
Rifaximin—Dizziness—Telmisartan—hypertension	5.36e-05	0.000123	CcSEcCtD
Rifaximin—Pruritus—Hydrochlorothiazide—hypertension	5.35e-05	0.000123	CcSEcCtD
Rifaximin—Decreased appetite—Ramipril—hypertension	5.35e-05	0.000123	CcSEcCtD
Rifaximin—Asthenia—Furosemide—hypertension	5.33e-05	0.000123	CcSEcCtD
Rifaximin—Rash—Clonidine—hypertension	5.33e-05	0.000123	CcSEcCtD
Rifaximin—Dermatitis—Clonidine—hypertension	5.33e-05	0.000123	CcSEcCtD
Rifaximin—Anorexia—Lisinopril—hypertension	5.32e-05	0.000122	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Ramipril—hypertension	5.31e-05	0.000122	CcSEcCtD
Rifaximin—Fatigue—Ramipril—hypertension	5.3e-05	0.000122	CcSEcCtD
Rifaximin—Headache—Clonidine—hypertension	5.3e-05	0.000122	CcSEcCtD
Rifaximin—Hypersensitivity—Losartan—hypertension	5.29e-05	0.000122	CcSEcCtD
Rifaximin—Asthenia—Betaxolol—hypertension	5.28e-05	0.000122	CcSEcCtD
Rifaximin—Nausea—Valsartan—hypertension	5.27e-05	0.000121	CcSEcCtD
Rifaximin—Pruritus—Furosemide—hypertension	5.26e-05	0.000121	CcSEcCtD
Rifaximin—Constipation—Ramipril—hypertension	5.26e-05	0.000121	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—ALDH2—hypertension	5.25e-05	0.00113	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARA—hypertension	5.25e-05	0.00113	CbGpPWpGaD
Rifaximin—Nausea—Olmesartan—hypertension	5.24e-05	0.000121	CcSEcCtD
Rifaximin—Vomiting—Trandolapril—hypertension	5.24e-05	0.000121	CcSEcCtD
Rifaximin—Diarrhoea—Perindopril—hypertension	5.23e-05	0.000121	CcSEcCtD
Rifaximin—Decreased appetite—Timolol—hypertension	5.23e-05	0.00012	CcSEcCtD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypertension	5.23e-05	0.00112	CbGpPWpGaD
Rifaximin—Vomiting—Enalapril—hypertension	5.22e-05	0.00012	CcSEcCtD
Rifaximin—Diarrhoea—Irbesartan—hypertension	5.22e-05	0.00012	CcSEcCtD
Rifaximin—Hypotension—Lisinopril—hypertension	5.21e-05	0.00012	CcSEcCtD
Rifaximin—Dizziness—Captopril—hypertension	5.21e-05	0.00012	CcSEcCtD
Rifaximin—Pruritus—Betaxolol—hypertension	5.21e-05	0.00012	CcSEcCtD
Rifaximin—Rash—Trandolapril—hypertension	5.2e-05	0.00012	CcSEcCtD
Rifaximin—Dermatitis—Trandolapril—hypertension	5.19e-05	0.00012	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Timolol—hypertension	5.19e-05	0.00012	CcSEcCtD
Rifaximin—Fatigue—Timolol—hypertension	5.18e-05	0.000119	CcSEcCtD
Rifaximin—Rash—Enalapril—hypertension	5.18e-05	0.000119	CcSEcCtD
Rifaximin—Dermatitis—Enalapril—hypertension	5.17e-05	0.000119	CcSEcCtD
Rifaximin—Diarrhoea—Hydrochlorothiazide—hypertension	5.17e-05	0.000119	CcSEcCtD
Rifaximin—Headache—Trandolapril—hypertension	5.17e-05	0.000119	CcSEcCtD
Rifaximin—Vomiting—Telmisartan—hypertension	5.15e-05	0.000119	CcSEcCtD
Rifaximin—Asthenia—Losartan—hypertension	5.15e-05	0.000119	CcSEcCtD
Rifaximin—Headache—Enalapril—hypertension	5.15e-05	0.000119	CcSEcCtD
Rifaximin—Pain—Timolol—hypertension	5.14e-05	0.000118	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—MYC—hypertension	5.14e-05	0.0011	CbGpPWpGaD
Rifaximin—Rash—Telmisartan—hypertension	5.11e-05	0.000118	CcSEcCtD
Rifaximin—Dermatitis—Telmisartan—hypertension	5.1e-05	0.000118	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP11A1—hypertension	5.09e-05	0.00109	CbGpPWpGaD
Rifaximin—Diarrhoea—Furosemide—hypertension	5.09e-05	0.000117	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Lisinopril—hypertension	5.08e-05	0.000117	CcSEcCtD
Rifaximin—Pruritus—Losartan—hypertension	5.08e-05	0.000117	CcSEcCtD
Rifaximin—Headache—Telmisartan—hypertension	5.08e-05	0.000117	CcSEcCtD
Rifaximin—Feeling abnormal—Ramipril—hypertension	5.07e-05	0.000117	CcSEcCtD
Rifaximin—Dizziness—Perindopril—hypertension	5.06e-05	0.000117	CcSEcCtD
Rifaximin—Insomnia—Lisinopril—hypertension	5.05e-05	0.000116	CcSEcCtD
Rifaximin—Dizziness—Irbesartan—hypertension	5.04e-05	0.000116	CcSEcCtD
Rifaximin—Diarrhoea—Betaxolol—hypertension	5.04e-05	0.000116	CcSEcCtD
Rifaximin—Gastrointestinal pain—Ramipril—hypertension	5.03e-05	0.000116	CcSEcCtD
Rifaximin—Nausea—Clonidine—hypertension	5.02e-05	0.000116	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP11A1—hypertension	5.02e-05	0.00108	CbGpPWpGaD
Rifaximin—Vomiting—Captopril—hypertension	5.01e-05	0.000115	CcSEcCtD
Rifaximin—Dizziness—Hydrochlorothiazide—hypertension	5e-05	0.000115	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—GSTT1—hypertension	5e-05	0.00107	CbGpPWpGaD
Rifaximin—Dyspnoea—Lisinopril—hypertension	4.97e-05	0.000115	CcSEcCtD
Rifaximin—Rash—Captopril—hypertension	4.97e-05	0.000114	CcSEcCtD
Rifaximin—Dermatitis—Captopril—hypertension	4.96e-05	0.000114	CcSEcCtD
Rifaximin—Feeling abnormal—Timolol—hypertension	4.96e-05	0.000114	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—GCLC—hypertension	4.94e-05	0.00106	CbGpPWpGaD
Rifaximin—Headache—Captopril—hypertension	4.94e-05	0.000114	CcSEcCtD
Rifaximin—Gastrointestinal pain—Timolol—hypertension	4.92e-05	0.000113	CcSEcCtD
Rifaximin—Dizziness—Furosemide—hypertension	4.92e-05	0.000113	CcSEcCtD
Rifaximin—Diarrhoea—Losartan—hypertension	4.91e-05	0.000113	CcSEcCtD
Rifaximin—Nausea—Trandolapril—hypertension	4.9e-05	0.000113	CcSEcCtD
Rifaximin—Urticaria—Ramipril—hypertension	4.89e-05	0.000113	CcSEcCtD
Rifaximin—Nausea—Enalapril—hypertension	4.88e-05	0.000112	CcSEcCtD
Rifaximin—Dizziness—Betaxolol—hypertension	4.87e-05	0.000112	CcSEcCtD
Rifaximin—Vomiting—Perindopril—hypertension	4.86e-05	0.000112	CcSEcCtD
Rifaximin—Abdominal pain—Ramipril—hypertension	4.86e-05	0.000112	CcSEcCtD
Rifaximin—Body temperature increased—Ramipril—hypertension	4.86e-05	0.000112	CcSEcCtD
Rifaximin—Decreased appetite—Lisinopril—hypertension	4.85e-05	0.000112	CcSEcCtD
Rifaximin—Vomiting—Irbesartan—hypertension	4.85e-05	0.000112	CcSEcCtD
Rifaximin—Rash—Perindopril—hypertension	4.82e-05	0.000111	CcSEcCtD
Rifaximin—Dermatitis—Perindopril—hypertension	4.82e-05	0.000111	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Lisinopril—hypertension	4.82e-05	0.000111	CcSEcCtD
Rifaximin—Nausea—Telmisartan—hypertension	4.81e-05	0.000111	CcSEcCtD
Rifaximin—Fatigue—Lisinopril—hypertension	4.81e-05	0.000111	CcSEcCtD
Rifaximin—Vomiting—Hydrochlorothiazide—hypertension	4.81e-05	0.000111	CcSEcCtD
Rifaximin—Rash—Irbesartan—hypertension	4.81e-05	0.000111	CcSEcCtD
Rifaximin—Dermatitis—Irbesartan—hypertension	4.8e-05	0.000111	CcSEcCtD
Rifaximin—Headache—Perindopril—hypertension	4.79e-05	0.00011	CcSEcCtD
Rifaximin—Urticaria—Timolol—hypertension	4.78e-05	0.00011	CcSEcCtD
Rifaximin—Headache—Irbesartan—hypertension	4.78e-05	0.00011	CcSEcCtD
Rifaximin—Pain—Lisinopril—hypertension	4.77e-05	0.00011	CcSEcCtD
Rifaximin—Constipation—Lisinopril—hypertension	4.77e-05	0.00011	CcSEcCtD
Rifaximin—Rash—Hydrochlorothiazide—hypertension	4.77e-05	0.00011	CcSEcCtD
Rifaximin—Dermatitis—Hydrochlorothiazide—hypertension	4.76e-05	0.00011	CcSEcCtD
Rifaximin—Abdominal pain—Timolol—hypertension	4.75e-05	0.00011	CcSEcCtD
Rifaximin—Body temperature increased—Timolol—hypertension	4.75e-05	0.00011	CcSEcCtD
Rifaximin—Dizziness—Losartan—hypertension	4.74e-05	0.000109	CcSEcCtD
Rifaximin—Headache—Hydrochlorothiazide—hypertension	4.74e-05	0.000109	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP17A1—hypertension	4.73e-05	0.00102	CbGpPWpGaD
Rifaximin—Vomiting—Furosemide—hypertension	4.73e-05	0.000109	CcSEcCtD
Rifaximin—Rash—Furosemide—hypertension	4.69e-05	0.000108	CcSEcCtD
Rifaximin—Dermatitis—Furosemide—hypertension	4.68e-05	0.000108	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—PTGS1—hypertension	4.68e-05	0.00101	CbGpPWpGaD
Rifaximin—Vomiting—Betaxolol—hypertension	4.68e-05	0.000108	CcSEcCtD
Rifaximin—Nausea—Captopril—hypertension	4.68e-05	0.000108	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP17A1—hypertension	4.67e-05	0.001	CbGpPWpGaD
Rifaximin—Headache—Furosemide—hypertension	4.66e-05	0.000107	CcSEcCtD
Rifaximin—Rash—Betaxolol—hypertension	4.64e-05	0.000107	CcSEcCtD
Rifaximin—Dermatitis—Betaxolol—hypertension	4.64e-05	0.000107	CcSEcCtD
Rifaximin—Headache—Betaxolol—hypertension	4.61e-05	0.000106	CcSEcCtD
Rifaximin—Feeling abnormal—Lisinopril—hypertension	4.6e-05	0.000106	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NOTCH1—hypertension	4.6e-05	0.000988	CbGpPWpGaD
Rifaximin—Gastrointestinal pain—Lisinopril—hypertension	4.56e-05	0.000105	CcSEcCtD
Rifaximin—Vomiting—Losartan—hypertension	4.56e-05	0.000105	CcSEcCtD
Rifaximin—Nausea—Perindopril—hypertension	4.54e-05	0.000105	CcSEcCtD
Rifaximin—Hypersensitivity—Ramipril—hypertension	4.53e-05	0.000104	CcSEcCtD
Rifaximin—Nausea—Irbesartan—hypertension	4.53e-05	0.000104	CcSEcCtD
Rifaximin—Rash—Losartan—hypertension	4.52e-05	0.000104	CcSEcCtD
Rifaximin—Dermatitis—Losartan—hypertension	4.52e-05	0.000104	CcSEcCtD
Rifaximin—Headache—Losartan—hypertension	4.49e-05	0.000104	CcSEcCtD
Rifaximin—Nausea—Hydrochlorothiazide—hypertension	4.49e-05	0.000103	CcSEcCtD
Rifaximin—Urticaria—Lisinopril—hypertension	4.43e-05	0.000102	CcSEcCtD
Rifaximin—Hypersensitivity—Timolol—hypertension	4.43e-05	0.000102	CcSEcCtD
Rifaximin—Nausea—Furosemide—hypertension	4.42e-05	0.000102	CcSEcCtD
Rifaximin—Asthenia—Ramipril—hypertension	4.41e-05	0.000102	CcSEcCtD
Rifaximin—Abdominal pain—Lisinopril—hypertension	4.41e-05	0.000102	CcSEcCtD
Rifaximin—Body temperature increased—Lisinopril—hypertension	4.41e-05	0.000102	CcSEcCtD
Rifaximin—Nausea—Betaxolol—hypertension	4.37e-05	0.000101	CcSEcCtD
Rifaximin—Pruritus—Ramipril—hypertension	4.35e-05	0.0001	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—PPARG—hypertension	4.34e-05	0.000932	CbGpPWpGaD
Rifaximin—Asthenia—Timolol—hypertension	4.31e-05	9.94e-05	CcSEcCtD
Rifaximin—Nausea—Losartan—hypertension	4.26e-05	9.82e-05	CcSEcCtD
Rifaximin—Pruritus—Timolol—hypertension	4.25e-05	9.8e-05	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypertension	4.24e-05	0.000911	CbGpPWpGaD
Rifaximin—Diarrhoea—Ramipril—hypertension	4.21e-05	9.7e-05	CcSEcCtD
Rifaximin—Diarrhoea—Timolol—hypertension	4.11e-05	9.48e-05	CcSEcCtD
Rifaximin—Hypersensitivity—Lisinopril—hypertension	4.11e-05	9.47e-05	CcSEcCtD
Rifaximin—Dizziness—Ramipril—hypertension	4.07e-05	9.37e-05	CcSEcCtD
Rifaximin—Asthenia—Lisinopril—hypertension	4e-05	9.22e-05	CcSEcCtD
Rifaximin—Dizziness—Timolol—hypertension	3.98e-05	9.16e-05	CcSEcCtD
Rifaximin—Pruritus—Lisinopril—hypertension	3.95e-05	9.09e-05	CcSEcCtD
Rifaximin—Vomiting—Ramipril—hypertension	3.91e-05	9.01e-05	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—SERPINE1—hypertension	3.91e-05	0.00084	CbGpPWpGaD
Rifaximin—Rash—Ramipril—hypertension	3.88e-05	8.93e-05	CcSEcCtD
Rifaximin—Dermatitis—Ramipril—hypertension	3.87e-05	8.93e-05	CcSEcCtD
Rifaximin—Headache—Ramipril—hypertension	3.85e-05	8.88e-05	CcSEcCtD
Rifaximin—Vomiting—Timolol—hypertension	3.82e-05	8.81e-05	CcSEcCtD
Rifaximin—Diarrhoea—Lisinopril—hypertension	3.82e-05	8.79e-05	CcSEcCtD
Rifaximin—Rash—Timolol—hypertension	3.79e-05	8.73e-05	CcSEcCtD
Rifaximin—Dermatitis—Timolol—hypertension	3.79e-05	8.73e-05	CcSEcCtD
Rifaximin—Headache—Timolol—hypertension	3.77e-05	8.68e-05	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP19A1—hypertension	3.74e-05	0.000805	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP19A1—hypertension	3.69e-05	0.000794	CbGpPWpGaD
Rifaximin—Dizziness—Lisinopril—hypertension	3.69e-05	8.5e-05	CcSEcCtD
Rifaximin—Nausea—Ramipril—hypertension	3.65e-05	8.42e-05	CcSEcCtD
Rifaximin—Nausea—Timolol—hypertension	3.57e-05	8.23e-05	CcSEcCtD
Rifaximin—Vomiting—Lisinopril—hypertension	3.55e-05	8.17e-05	CcSEcCtD
Rifaximin—Rash—Lisinopril—hypertension	3.52e-05	8.1e-05	CcSEcCtD
Rifaximin—Dermatitis—Lisinopril—hypertension	3.51e-05	8.1e-05	CcSEcCtD
Rifaximin—Headache—Lisinopril—hypertension	3.49e-05	8.05e-05	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—COMT—hypertension	3.48e-05	0.000748	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—COMT—hypertension	3.43e-05	0.000738	CbGpPWpGaD
Rifaximin—Nausea—Lisinopril—hypertension	3.31e-05	7.63e-05	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—GSTM1—hypertension	3.18e-05	0.000684	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	3.14e-05	0.000675	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP1A1—hypertension	3.02e-05	0.000649	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FAH—hypertension	2.98e-05	0.00064	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	2.98e-05	0.00064	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—MYC—hypertension	2.47e-05	0.000532	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HYAL2—hypertension	2.26e-05	0.000485	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HAS3—hypertension	2.26e-05	0.000485	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HAS2—hypertension	2.26e-05	0.000485	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PNMT—hypertension	2.26e-05	0.000485	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HAS1—hypertension	2.26e-05	0.000485	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—QDPR—hypertension	2.26e-05	0.000485	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—POMC—hypertension	2.25e-05	0.000484	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTA5—hypertension	2.12e-05	0.000456	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MDH1—hypertension	2.01e-05	0.000432	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HYAL1—hypertension	2.01e-05	0.000432	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CDO1—hypertension	2.01e-05	0.000432	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTT2—hypertension	2.01e-05	0.000432	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CPS1—hypertension	2.01e-05	0.000432	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP4F12—hypertension	1.92e-05	0.000413	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCH1—hypertension	1.92e-05	0.000413	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLCD1—hypertension	1.84e-05	0.000396	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AHCY—hypertension	1.77e-05	0.000381	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP11B1—hypertension	1.77e-05	0.000381	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AKT1—hypertension	1.72e-05	0.000369	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTM5—hypertension	1.71e-05	0.000368	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALOX12—hypertension	1.71e-05	0.000368	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DBH—hypertension	1.71e-05	0.000368	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GBA—hypertension	1.71e-05	0.000368	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—EPHX2—hypertension	1.71e-05	0.000368	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2J2—hypertension	1.66e-05	0.000356	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ARG1—hypertension	1.61e-05	0.000346	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GLS2—hypertension	1.61e-05	0.000346	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COX5B—hypertension	1.61e-05	0.000346	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DECR1—hypertension	1.61e-05	0.000346	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALAD—hypertension	1.52e-05	0.000328	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH7A1—hypertension	1.45e-05	0.000313	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLCE1—hypertension	1.45e-05	0.000313	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—STS—hypertension	1.45e-05	0.000313	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP4A11—hypertension	1.39e-05	0.0003	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CBS—hypertension	1.39e-05	0.0003	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ARG2—hypertension	1.39e-05	0.0003	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—XDH—hypertension	1.37e-05	0.000294	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGIS—hypertension	1.34e-05	0.000289	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP3A5—hypertension	1.34e-05	0.000289	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC5A2—hypertension	1.34e-05	0.000289	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UCP2—hypertension	1.3e-05	0.000279	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD11B1—hypertension	1.3e-05	0.000279	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TPH1—hypertension	1.3e-05	0.000279	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCC1—hypertension	1.3e-05	0.000279	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UCP3—hypertension	1.3e-05	0.000279	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP11B2—hypertension	1.26e-05	0.00027	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALAS1—hypertension	1.26e-05	0.00027	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A3—hypertension	1.26e-05	0.00027	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD3B1—hypertension	1.24e-05	0.000266	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADA—hypertension	1.24e-05	0.000266	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FADS1—hypertension	1.22e-05	0.000262	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AQP1—hypertension	1.22e-05	0.000262	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA9—hypertension	1.19e-05	0.000255	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TBXAS1—hypertension	1.19e-05	0.000255	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALOX5AP—hypertension	1.16e-05	0.000248	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALOX15—hypertension	1.16e-05	0.000248	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LHB—hypertension	1.13e-05	0.000242	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HADHA—hypertension	1.13e-05	0.000242	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPA—hypertension	1.1e-05	0.000237	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD3B2—hypertension	1.1e-05	0.000237	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—KCNJ11—hypertension	1.1e-05	0.000237	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LRP2—hypertension	1.06e-05	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2C18—hypertension	1.06e-05	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSPG2—hypertension	1.02e-05	0.000219	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GLP1R—hypertension	9.83e-06	0.000211	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALOX5—hypertension	9.83e-06	0.000211	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH2—hypertension	8.99e-06	0.000193	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HBA1—hypertension	8.76e-06	0.000188	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP11A1—hypertension	8.7e-06	0.000187	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTT1—hypertension	8.55e-06	0.000184	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC9A1—hypertension	8.55e-06	0.000184	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCLC—hypertension	8.45e-06	0.000182	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CETP—hypertension	8.45e-06	0.000182	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP17A1—hypertension	8.09e-06	0.000174	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ENO1—hypertension	8.01e-06	0.000172	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS1—hypertension	8.01e-06	0.000172	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CTGF—hypertension	7.71e-06	0.000166	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT2—hypertension	7.64e-06	0.000164	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMGCR—hypertension	7.64e-06	0.000164	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADRA2A—hypertension	7.48e-06	0.000161	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TH—hypertension	7e-06	0.00015	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CALM2—hypertension	6.98e-06	0.00015	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A4—hypertension	6.81e-06	0.000146	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCG—hypertension	6.81e-06	0.000146	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT1—hypertension	6.6e-06	0.000142	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—STK11—hypertension	6.4e-06	0.000138	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP19A1—hypertension	6.4e-06	0.000138	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COMT—hypertension	5.95e-06	0.000128	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARGC1A—hypertension	5.87e-06	0.000126	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GNB3—hypertension	5.87e-06	0.000126	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMOX1—hypertension	5.84e-06	0.000126	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CAT—hypertension	5.77e-06	0.000124	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GNAS—hypertension	5.72e-06	0.000123	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOB—hypertension	5.6e-06	0.00012	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTM1—hypertension	5.44e-06	0.000117	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPL—hypertension	5.34e-06	0.000115	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADCY5—hypertension	5.23e-06	0.000112	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX1—hypertension	5.21e-06	0.000112	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PRKCA—hypertension	5.16e-06	0.000111	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP1A1—hypertension	5.16e-06	0.000111	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CD36—hypertension	5.08e-06	0.000109	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MTHFR—hypertension	4.81e-06	0.000103	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARA—hypertension	4.72e-06	0.000101	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AGT—hypertension	4.57e-06	9.83e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CALM1—hypertension	4.5e-06	9.66e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOE—hypertension	4.48e-06	9.63e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CAV1—hypertension	4.44e-06	9.54e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA1—hypertension	4.43e-06	9.52e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARG—hypertension	3.9e-06	8.39e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—POMC—hypertension	3.85e-06	8.27e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—INS—hypertension	3.83e-06	8.23e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—hypertension	3.51e-06	7.54e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3R1—hypertension	3.36e-06	7.21e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NOS3—hypertension	3.36e-06	7.21e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—hypertension	3.07e-06	6.6e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTEN—hypertension	2.68e-06	5.75e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—EP300—hypertension	2.55e-06	5.49e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKT1—hypertension	1.54e-06	3.32e-05	CbGpPWpGaD
